BRIEF

on Biotest AG (ETR:BIO)

Biotest AG Under Review for Legal Structure Change

Stock price chart of Biotest AG (EBR:BIO) showing fluctuations.

Biotest AG has received a formal request from its majority shareholder, Grifols S.A., to convene an extraordinary general meeting. The agenda includes a proposal to transform Biotest AG from a stock corporation into a partnership limited by shares, known as Biotest GmbH & Co. KGaA.

If approved, a new entity, Biotest Management GmbH, will join as the general partner with unlimited liability. The firm's name will change accordingly, but shareholder rights and shares will remain unchanged. The Management Board is tasked with evaluating the compliance of this request with the German Stock Corporation Act before any meeting is convened and determining whether to support the proposal or suggest alternatives.

This move signifies a potentially pivotal shift in the company's legal and operational structure.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Biotest AG news